Scholars Central

Conference abstractPublished 4 Sep 2017

Antihyperalgesic activities of endocannabinoids in a mouse model of antiretroviral-induced neuropathic pain

Authors: Neha Munawar

Kuwait University, Kuwait

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Statement of the Problem: Development of a painful sensory neuropathy sometimes limits the use of nucleoside reverse transcriptase inhibitors (NRTIs) in HIV/AIDS management. Cannabis has been reported in clinical trials to have efficacy in relieving painful HIV-associated sensory neuropathy. The purpose of this study is to evaluate whether the endocannabinoid system plays a role in NRTI-induced painful neuropathy. Methodology & Theoretical Orientation: Female BALB/c mice were treated with 25 mg/kg of 2âÂ?²,3âÂ?²-dideoxycytidine (ddC), a NRTI, to induce painful neuropathy. The expression of the endocannabinoid system molecules was evaluated by real-time PCR in the brain, spinal cord and paw skin at six days post ddC administration. The effects of the endocannabinoids, N-arachidonoyl ethanolamine (AEA), 2-arachidonoyl glycerol (2-AG), cannabinoid receptor antagonists, AM 251 and AM 630, and G proteincoupled receptor 55 antagonist ML193 on ddC-induced thermal hyperalgesia were evaluated using the hot plate test. Findings: Mice treated with ddC developed mechanical and cold allodynia, and thermal hyperalgesia. Treatment with ddC increased transcripts of phospholipase C-Ã?²1, but not of other enzymes involved in the synthesis of endocannabinoids, only in the paw skin compared to vehicle-treatment. The transcripts of the inactivating enzymes, fatty acid amide hydrolase and monoacyl glycerol, were downregulated only in the brain and paw skin, respectively, of ddC-treated mice. AEA and 2-AG had antihyperalgesic effects against ddC-induced thermal hyperalgesia, but had no effect in naÃ?¯ve mice. The antihyperalgesic activity of AEA was antagonized by AM251 and AM630, whereas the activity of 2-AG was antagonized by AM251 and ML193, but not by AM630. Conclusion & Significance: Our results show that ddC induces painful neuropathy, which is associated with dysregulation of the endocannabinoid system. Agonists of cannabinoid receptors could be useful therapeutic agents for the management of NRTI-induced painful sensory neuropathy.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalBiochemistry & Pharmacology: Open Access
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Neha Munawar”